002898 Sailong Pharmaceutical Group
- 10.50
- +0.74+7.58%
About Sailong Pharmaceutical Group Company
The company was founded in 2002 and is a high-tech enterprise integrating R&D, production and sales of pharmaceuticals. Currently, its products are mainly concentrated in the fields of nervous system, cardiovascular system and digestive system. The company belongs to the pharmaceutical manufacturing industry. Adhering to the corporate purpose of “leading science and technology to achieve the cause of health”, it has built a modern pharmaceutical enterprise integrating R&D, production, marketing and technical services of pharmaceutical intermediates, APIs, and formulations. The company's main products include injectable esomeprazole sodium and APIs, aspartate ornithine injections and APIs, injectable thymic acid injections, agatroban injections and APIs, injectable tigacycline and APIs, tetrahexose ganglioside sodium monosalate injections and APIs, injectable brain protein hydrolysates (III), mirinone injections and APIs, injectable parecoxib sodium and APIs, tranexamic acid injections, injectable clindamycin phosphate, pantoprazole for injections Sodium, etc., covering cardiovascular, neurological, digestive system, proton pump inhibitors, anti-infective drugs, anti-hemorrhagic drugs , analgesics and other fields.
Company Profile
Company Executives
- Name
- Position
- Salary
- nangui cai
- Chairman, Directors, President, Chairman of the Strategic Decision Committee
- 511.40K
- dawen liu
- Directors, Executive Vice President, Nomination Committee Members, Member of the Strategic Decision Committee, Member of the Remuneration and Assessment Committee
- 568.60K
- lin tang
- Directors, Audit Committee Member, Member of the Strategic Decision Committee
- 401.80K
- xu zhang
- Directors, Board Secretary, Deputy General Manager, Member of the Strategic Decision Committee
- 483.00K
- jianfeng li
- Directors, Deputy General Manager, Member of the Strategic Decision Committee
- 445.30K
- yongjun deng
- Directors, Member of the Strategic Decision Committee
- 403.10K
- gongfen li
- Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
- 100.00K
- chuanyun pan
- Independent Directors, Chairman of the Audit Committee, Nomination Committee Members
- 120.00K
- xiaoxin chen
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
- 120.00K
- haiyan tan
- Securities Affairs Representative
- --
- zhixiang long
- Chairman of the Supervisory Board, Auditors
- 359.20K
- bei zhou
- Auditors
- 355.10K
- daifeng duan
- VP
- --
- xing wang
- Deputy General Manager
- 524.50K
- jing gao
- Chief Financial Officer
- 370.30K
- xingyan luo
- Head of Internal Audit
- --
- haibo huang
- Employee Supervisors
- 320.30K
Analysis
Price Target
No Data
